Nasdaq Stockholm

S2Medical AB (publ)

ISIN SE0011725084Filings at the FI

At a glance

Most recent filing on July 15, 2021 — an open-market purchase by SivlerSkog Group AB on Jul 12, 2021.

We hold 21 visible filings, going back to January 28, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 21 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 21. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

SivlerSkog Group AB Chief executive officer, Deputy chief executive officer, Board member
100,575 SEKOpen-market buy
TradedJul 12, 2021FiledJul 15, 2021
Arbona Growth AB Closely associated: Board member or deputy board member
2,608,687 SEKOpen-market sale
TradedMar 17, 2020FiledMar 19, 2020
Arbona Growth AB Closely associated: Board member or deputy board member
360,097 SEKOpen-market sale
TradedMar 16, 2020FiledMar 19, 2020
Johan Thorfinn Chief of Clinical Operations
23,667 SEKOpen-market buy
TradedMay 24, 2019FiledMay 24, 2019
Johan Thorfinn Chief of Clinical Operations
10,250 SEKOpen-market buy
TradedMay 24, 2019FiledMay 24, 2019